Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

被引:8
作者
Daly, Megan E. [1 ]
Singh, Navneet [2 ]
Ismaila, Nofisat [3 ]
机构
[1] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA
[2] Postgrad Inst Med Educ & Res, Chandigarh, India
[3] Amer Soc Clin Oncol, Alexandria, VA 22314 USA
关键词
D O I
10.1200/JCO-24-01324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).
引用
收藏
页码:3058 / 3060
页数:5
相关论文
共 50 条
[41]   RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC) [J].
De Ruysscher, D. .
LUNG CANCER, 2009, 64 :S21-S21
[42]   The role of radiotherapy in stage III non-small cell lung cancer [J].
Jassem, J. .
LUNG CANCER, 2006, 52 :S4-S5
[43]   The role of biomarkers in stage III non-small cell lung cancer [J].
Rosell, Rafael ;
Gonzalez-Cao, Maria ;
Ito, Masaoki ;
Santarpia, Mariacarmela ;
Aguilar, Andres ;
Codony-Servat, Jordi .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (06) :469-480
[44]   Multimodality therapy in stage III non-small cell lung cancer [J].
Edelman, MJ ;
Gandara, DR ;
Roach, M ;
Benfield, JR .
ANNALS OF THORACIC SURGERY, 1996, 61 (05) :1564-1572
[45]   Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update [J].
Seth, Rahul ;
Messersmith, Hans ;
Funchain, Pauline .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) :2375-+
[46]   Audit of stage III non-small cell lung cancer (NSCLC) management in the Essex Cancer Network [J].
Reinius, M. ;
Malek, A. ;
Powrie, D. ;
Yung, B. ;
Ingle, C. ;
Islam, M. R. ;
Dancey, G. .
LUNG CANCER, 2019, 127 :S8-S8
[47]   Guideline Concordant Care is Associated with Better Survival for Patients with Stage III Non-Small Cell Lung Cancer [J].
Ahmed, Hiba ;
Liu, Yuan ;
O'Conne, Kelli ;
Gillespie, Theresa ;
Ahmed, Maaz ;
Pate, Pretest ;
Pillai, Rathi ;
Behera, Madhusmita ;
Steuer, Conor ;
Owonikoko, Taofeek ;
Ramalingam, Suresh ;
Curran, Walter ;
Higgins, Kristin .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S855-S856
[48]   Management of unresectable stage III non-small cell lung cancer: The role of combined chemoradiation [J].
Penland, SK ;
Socinski, MA .
SEMINARS IN RADIATION ONCOLOGY, 2004, 14 (04) :326-334
[49]   Patterns of Care in the Management of Stage III Non-small Cell Lung Cancer in the Medicare Population [J].
Chen, A. B. ;
Neville, B. A. ;
Schrag, D. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03) :S11-S12
[50]   Is Opioid Use in the Management of Stage III Non-Small Cell Lung Cancer Patients Necessary? [J].
Gorgens, U. ;
Higgins, K. ;
Bradley, J. ;
Stokes, B. ;
Leal, T. ;
Kesarwala, A. H. ;
Tian, S. ;
McCall, N. .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S133-S133